95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
View analysts' price targets and recommendations, and compare them with competitors.
$100.50
Analysts expect the stock price to increase by 3.93%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
883.94M
The estimated revenue has increased from the previous period.
613.55M
The estimated EBITDA has increased from the previous period.
0.60
The estimated EPS has increased from the previous period.
271.99M
The estimated net income has increased from the previous period.
405.25M
The estimated EBIT has increased from the previous period.
47.78M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
1.13B
Revenue has increased from the previous period.
5.23%
Revenue growth rate is unchanged from the previous period.
782.45M
EBITDA has increased from the previous period.
69.55%
EBITDA margin is unchanged from the previous period.
517.32M
EBIT has increased from the previous period.
45.98%
EBIT margin is unchanged from the previous period.
265.13M
Depreciation has increased from the previous period.
377.15M
Total cash has increased from the previous period.
33.52%
Cash percentage is unchanged from the previous period.
10.09M
Receivables have increased from the previous period.
0.90%
Receivables percentage is unchanged from the previous period.
15.49M
Inventories have increased from the previous period.
1.38%
Inventory percentage is unchanged from the previous period.
14.00M
Accounts payable has increased from the previous period.
1.24%
Payables percentage is unchanged from the previous period.
-253.96M
Capital expenditure has increased from the previous period.
-22.57%
CapEx percentage is unchanged from the previous period.
7.76%
WACC is unchanged from the previous period.
7.74%
Cost of equity is unchanged from the previous period.
88.46%
Cost of debt is unchanged from the previous period.
0.71
Beta is unchanged from the previous period.
453.46M
Diluted shares outstanding is unchanged from the previous period.
6.23M
Total debt is unchanged from the previous period.
25.95B
Total equity is unchanged from the previous period.
25.95B
Total capital is unchanged from the previous period.
0.02%
Debt weighting is unchanged from the previous period.
99.98%
Equity weighting is unchanged from the previous period.
516.97M
EBIAT has increased from the previous period.
527.56M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
10.89B
Terminal value is unchanged from the previous period.
9.71B
Enterprise value is unchanged from the previous period.
-540.30M
Net debt is unchanged from the previous period.
10.25B
Equity value is unchanged from the previous period.
22.61
Equity value per share is unchanged from the previous period.
